- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
BIIB Market Currents
more »
-
Thursday 1:10 PM Biogen (BIIB +0.3%) hovers in the green on positive comments out of BMO Capital this morning. The firm believe the stock is poised to move higher due to several upcoming catalysts, including the company's R&D day on June 12 and two upcoming data releases. The firm expects the stock to make a move towards $145 over the near term.
Comment![Healthcare]
BIIB in Focus
more »
BIIB Related Articles
more »
BIIB News
more »
-
at MarketWatch.com (May 1, 2012)
-
at CNBC.com (Apr 30, 2012)
-
at CNBC.com (Apr 27, 2012)
-
at CNBC.com (Apr 11, 2012)
-
at CNBC.com (Apr 4, 2012)
BIIB Press Releases and Filings
more »
-
Business Wire (May 14, 2012)
-
Business Wire (May 9, 2012)
-
Business Wire (May 9, 2012)
-
Business Wire (May 2, 2012)
-
Business Wire (May 1, 2012)
BIIB Latest Transcript
more »
BIIB Cramer
more »
BIIB Instablog posts
more »
BIIB vs. ETF Alternatives
Company Description
Biogen Idec is a global biotechnology company that creates new standards of care in therapeutic areas with high unmet medical needs. Our business strategy is focused on discovering and developing first-in-class or best-in-class products that we can deliver to specialty markets globally.... More
